Tam Yu Tong, Kannan Aadithya, Chakravarty Paroma, Bui Minhthi, Mistler William, Whang Kevin, Sreedhara Alavattam
Pharmaceutical Development, Genentech Inc., South San Francisco, California 94080, United States.
Synthetic Molecule Pharmaceutical Sciences, Genentech Inc., South San Francisco, California 94080, United States.
Mol Pharm. 2025 Aug 4;22(8):4983-4994. doi: 10.1021/acs.molpharmaceut.5c00639. Epub 2025 Jul 10.
Developing a stabilized spray-dried formulation for proteins is one key approach to extending the stability of a dehydrated drug product and providing a broad range of different drug delivery applications. Trehalose has been extensively studied as an excipient to preserve the protein stability in spray-dried formulations. However, the hygroscopic nature of amorphous trehalose makes it prone to recrystallization upon exposure to high temperature and humidity conditions, which can be detrimental to protein stability in the solid state. Herein, we report a formulation approach with the use of 2-hydroxypropyl-β-cyclodextrin (HPβCD) in combination with trehalose to enhance the physical stability of spray-dried solids by inhibiting or delaying the recrystallization of trehalose. Specifically, the effect of HPβCD and trehalose as an excipient alone or the combination of both excipients in stabilizing a model therapeutic monoclonal antibody (mAb1) in a spray-dried formulation has been evaluated at 25 °C/60% relative humidity (RH) and 40 °C/75% RH over 4 weeks. In the solid state, HPβCD can inhibit trehalose recrystallization of spray-dried solids exposed to stress conditions of higher temperatures and humidity. The recrystallization tendency of trehalose was found to be dependent on the protein-to-excipient mass ratios. At a 1:1 protein-to-excipient mass ratio, trehalose is insufficient to ensure adequate protein stability after stress under high humidity, which leads to a significant change in conformational stability and the highest degree of subvisible particle formation for mAb1, primarily due to trehalose recrystallization and high-temperature stresses, while the combination of HPβCD and trehalose has resulted in improved protein stability with a reduction in aggregation propensity. These results show that a combination of HPβCD and trehalose is a viable approach in mitigating trehalose recrystallization and maintaining protein stability of mAbs in spray-dried formulations.
开发用于蛋白质的稳定化喷雾干燥制剂是延长脱水药物产品稳定性并提供广泛不同药物递送应用的一种关键方法。海藻糖作为一种辅料,已被广泛研究用于在喷雾干燥制剂中保持蛋白质稳定性。然而,无定形海藻糖的吸湿性使其在暴露于高温和高湿度条件下时容易发生重结晶,这可能对固态蛋白质稳定性有害。在此,我们报告一种制剂方法,即使用2-羟丙基-β-环糊精(HPβCD)与海藻糖结合,通过抑制或延缓海藻糖的重结晶来提高喷雾干燥固体的物理稳定性。具体而言,已在25℃/60%相对湿度(RH)和40℃/75%RH条件下评估了4周,单独使用HPβCD和海藻糖作为辅料或两种辅料组合在喷雾干燥制剂中稳定模型治疗性单克隆抗体(mAb1)的效果。在固态下,HPβCD可以抑制暴露于更高温度和湿度应激条件下的喷雾干燥固体中海藻糖的重结晶。发现海藻糖的重结晶趋势取决于蛋白质与辅料的质量比。在蛋白质与辅料质量比为1:1时,海藻糖不足以确保在高湿度应激后蛋白质具有足够的稳定性,这导致mAb1的构象稳定性发生显著变化以及亚可见颗粒形成程度最高,主要是由于海藻糖重结晶和高温应激,而HPβCD和海藻糖的组合提高了蛋白质稳定性并降低了聚集倾向。这些结果表明,HPβCD和海藻糖的组合是减轻海藻糖重结晶并维持喷雾干燥制剂中mAb蛋白质稳定性的一种可行方法。